** Shares of Biocon BION.NS rise 3.4% to 364.5 rupees
** Stock top gainer on Nifty Pharma Index .NIPHARM, which is up 0.54%
** BION said on Monday unit Biocon Biologics fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris
** Unit also completes full and final remittance of considerations toward Viatris
** 16 analysts covering the stock on avg have a "hold" rating; median PT is 334.5 rupees - LSEG data
** Stock up 46% YTD vs a 38% gain in NIPHARM
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。